IP Library › Granted Patent US 10,916,331
Granted Patent B2
US 10,916,331 · App. 15/577,719 · Granted Feb 9, 2021

Predicting drug-target interactions and uses for drug repositioning and repurposing

Inventors: Sivanesan Dakshanamurthy (Herndon, VA); Stephen W. Byers (Takoma Park, MD)
Assignee: GEORGETOWN UNIVERSITY
G16B15/00G06F5/01G06F17/11G16B15/30G06F2111/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,916,331
App. No.
15/577,719
Granted
Feb 9, 2021
Kind
B2
Abstract

Described herein are methods of predicting drug-target interactions and methods of using the information for drug repurposing. The methods described herein combine different descriptors, including, for example, atom pair similarity, shape, topology and chemical signatures, physico-chemical functional descriptors, contact points of the ligand and the target protein, chemical similarity, and docking score.

Claims (132)

1. A method for identifying protein-drug interactions, the method comprising:

receiving test ligand molecular data corresponding to a test ligand that is a candidate drug;

receiving protein molecular data corresponding to a protein;

receiving reference ligand data corresponding to a reference ligand that binds to the protein;

generating, by a computer system, an atom pair score from an atom descriptor of the test ligand and a corresponding atom descriptor of the reference ligand;

calculating an interaction score, the interaction score including a sum comprising the atom pair score;

normalizing the interaction score using a normalization weight calculated using the formula N ∝ =1−|1−S ∝ (x)|, wherein x is a raw parameter, S(x) is a sigmoid function, and a is a tunable scalar coefficient chosen to maximize an information-preserving variance in an image of N(x);

validating, based on the interaction score exceeding a threshold value, a first interaction between the test ligand and the protein;

in response to validating the first interaction, performing an assay using the test ligand and the protein to obtain an assay result experimentally;

after validating the first interaction, receiving the assay result; and

confirming the first interaction based at least on the received assay result.

2. The method of claim 1 , further comprising:

calculating, by the computer system, a shape score including one or more shape contributions, each shape contribution corresponding to a respective shape descriptor, wherein a respective contribution includes a first part and a second part, the first part providing a first shape score from a first respective shape function of the protein and the test ligand corresponding to the respective shape descriptor, and the second part providing a second shape score from a second respective shape function of the reference ligand and the test ligand corresponding to the respective shape descriptor;

calculating, by the computer system, a total similarity score including one or more similarity contributions, each similarity contribution corresponding to a respective similarity descriptor, wherein a respective similarity contribution provides a respective similarity score between a respective similarity function of the test ligand and the respective similarity function of the reference ligand;

calculating, by the computer system, a correction score, the correction score being a difference between a first sum and a second sum, the first sum being of energies of contact points between the reference ligand and the protein; and adding the shape score, the similarity score, and the correction score to the interaction score.

3. The method of claim 2 , further comprising:

calculating a docking score between the test ligand and the protein; and adding the docking score to the interaction score.

4. The method of claim 3 , further comprising:

normalizing the interaction score using weights for the atom pair score, the first respective shape functions, the second respective shape functions, and the docking score.

5. The method of claim 3 , wherein the interaction score Z for a qth test ligand, a pth protein, and a rth reference ligand is calculated using the formula:

Z

⁡

(

q

,

p

,

r

)

=

ω

j

⁢

Y

⁡

(

p

,

q

)

+

ω

k

⁢

P

⁡

(

r

,

q

)

+

∑

m

=

1

M

⁢

[

ω

m

⁢

f

m

⁡

(

p

,

q

)

+

ω

m

′

⁢

f

m

′

⁡

(

r

,

qp

,

q

)

]

+

∑

n

=

1

N

⁢

X

n

⁡

(

r

,

q

)

+

CS

⁡

(

OLIC

)

.

6. The method of claim 2 , wherein the one or more shape contributions include a Euclidean distance metric.

7. The method of claim 2 , wherein the one or more similarity contributions include at least one of: a number of H-bond acceptors, number of H-bond donors, dipole, electron affinity, globularity, molecular weight, ClogP, number of rotatable bonds, solvent-accessible surface area, and volume.

8. The method of claim 2 , wherein:

the first sum of the correction score for a pth protein is computed as: S(OLIC−r) p =Σ n=1 NR ω n E n,p ,

where NR is a number of contact points between the reference ligand and the protein, ω n is a weighting factor for the nth contact point, and E n,p is an energy associated with the nth contact point.

9. The method of claim 2 , wherein:

the second sum of the correction score for a qth test ligand and a pth protein is computed as: S(OLIC−q) p =Σ n=1 NQ ω n E n,q,p , where NQ is a number of contact points between the test ligand and the protein, ω n is a weighting factor for the nth contact point, and E n,p,q is an energy associated with the nth contact point.

10. The method of claim 1 , wherein a portion of the reference ligand data is extracted from a known structure of a complex of the protein bound to the reference ligand.

11. The method of claim 1 , wherein calculating the atom pair score includes a similarity Tanimoto coefficient.

12. A computer product comprising a non-transitory computer readable medium storing a plurality of instructions for controlling a computer system to perform the method of claim 1 .

13. A system comprising:

the computer product of claim 12 ; and

one or more processors for executing instructions stored on the computer readable medium.

14. The method of claim 1 , wherein the assay comprises a kinase assay.

15. The method of claim 1 , wherein:

the test ligand is a first test ligand, and

the method further comprises:

calculating interaction scores for 39 additional test ligands in the same manner as for the first test ligand.

16. The method of claim 1 , wherein the threshold value is a score value.

17. The method of claim 1 , further comprising:

determining a plurality of interaction scores for a plurality of test ligands and protein combinations;

ranking the plurality of interaction scores; and

using a ranking as the threshold value.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2018
From: DAKSHANAMURTHY, SIVANESAN; BYERS, STEPHEN W.
To: GEORGETOWN UNIVERSITY
Reel/Frame 046506/0793 →
Continuity (2)
Provisional Application 62172639 · Jun 8, 2015
Related Publication 20180157786A1 · Jun 7, 2018